Obesity/Glucose Metabolic Disorders – Perseus SENOLYTIX

Obesity/Glucose Metabolic Disorders

Unintended risks of sarcopenic obesity during weight-loss interventions in older people

February 5, 2026

Inhibition Of IL-11 Signalling Extends Mammalian Healthspan and Lifespan

June 11, 2024

Prophylactic and Long-Lasting Efficacy of Senolytic CAR T Cells Against Age-Related Metabolic Dysfunction

January 24, 2024

Targeting Senescent Cells Alleviates Obesity‐Induced Metabolic Dysfunction

January 25, 2019

© 2026 Perseus SENOLYTIX.